Neurotensin and neuromedin N are differently metabolized in ventral tegmental area and nucleus accumbens.
Whole homogenates and membrane-bound and cytosoluble fractions prepared from rat ventral tegmental area (VTA) and nucleus accumbens were examined for their content of peptidasic activities and for their ability to metabolize neurotensin and its natural related hexapeptide neuromedin N. No qualitative differences were observed between these two brain regions concerning the presence and the subcellular distribution of a series of activities able to hydrolyze various specific fluorimetric enzymatic substrates. However, aminopeptidase B, endopeptidase 24-15, and endopeptidase 24-11 were significantly lower in the VTA than in the nucleus accumbens membrane preparations, while proline endopeptidase was detected in significantly higher amount only in the cytosolic fraction prepared from nucleus accumbens. Both neurotensin and neuromedin N were metabolized more rapidly in the nucleus accumbens than in the VTA. Furthermore, the degradation rate of neuromedin N was considerably faster than that of neurotensin whatever the cerebral area examined. Studies carried out with highly specific peptidase inhibitors revealed that endopeptidase 24-15 mainly contributed to the catabolism of neurotensin in homogenates and membrane-bound preparations of nucleus accumbens and VTA, while aminopeptidase B appeared predominantly responsible for the rapid disappearance of neuromedin N in both cerebral tissues. The possibility that the different metabolic processes of the two peptide congeners could explain their distinct pharmacological profiles observed after their microinjection in the nucleus accumbens and in the VTA is discussed.
Checler
F
F
Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, Valbonne, France.
Dauch
P
P
Masuo
Y
Y
Vincent
J P
JP
D000818:Animals; D008297:Male; D009479:Neuropeptides / Q000378:metabolism; D009496:Neurotensin / Q000378:metabolism*; D009714:Nucleus Accumbens / Q000201:enzymology / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism*; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013681:Tegmentum Mesencephali / Q000201:enzymology / Q000378:metabolism*
D009479:Neuropeptides; D010446:Peptide Fragments; D011480:Protease Inhibitors; C042090:neuromedin N; D009496:Neurotensin